T-Cell Therapy Market Size to Hit $21+ Billion with Booming CAGR Value of 20.7% by 2028 | The Insight Partners
20 oct. 2022 09h22 HE
|
The Insight Partners
New York, Oct. 20, 2022 (GLOBE NEWSWIRE) -- According to The Insight Partners latest study on "T-cell Therapy Market Size, Share, Trends, Growth Strategy and Forecast to 2028 – COVID-19 Impact and...
Scitech and the Plough Center Announce Manufacturing Agreement
20 oct. 2022 09h00 HE
|
SciTech Development
GROSSE POINTE FARMS, Mich., Oct. 20, 2022 (GLOBE NEWSWIRE) -- SciTech Development is pleased to announce that it has signed a $600K manufacturing agreement with The Plough Center for Sterile Drug...
Florida Cancer Specialists & Research Institute First in Palm Beach County To Offer Targeted Radioligand Therapy for Metastatic Prostate Cancer
12 oct. 2022 13h40 HE
|
Florida Cancer Specialists & Research Institute
Fort Myers, Fla., Oct. 12, 2022 (GLOBE NEWSWIRE) -- Florida Cancer Specialists & Research Institute locations in Palm Beach County are now offering Pluvicto ™, the first targeted radioligand...
Skin Cancer Treatment Market to Reach USD 14.5 Billion by 2031, Says Allied Market Research
11 oct. 2022 11h30 HE
|
Allied Market Research
Portland, OR, Oct. 11, 2022 (GLOBE NEWSWIRE) -- According to the report published by Allied Market Research, the global skin cancer treatment market generated $7.2 billion in 2021, and is estimated...
Sigyn Therapeutics™ Announces Cancer-Related Patent Submission Entitled: “System and Methods to Enhance Chemotherapy Delivery and Reduce Toxicity”
06 oct. 2022 08h30 HE
|
Sigyn Therapeutics, Inc.
SAN DIEGO, CA, Oct. 06, 2022 (GLOBE NEWSWIRE) -- via NewMediaWire – Sigyn Therapeutics, Inc. (“Sigyn” or the “Company”) (OTCQB: SIGY), a development-stage company focused on creating therapeutic...
Global Multi Cancer Early Detection Market Size/Share Worth 3186.8 Million by 2030 at a 16.5% CAGR: Custom Market Insights (Share, Report, Trends, Forecast, Trends, Segmentation)
05 oct. 2022 07h30 HE
|
Custom Market Insights
Sandy, USA, Oct. 05, 2022 (GLOBE NEWSWIRE) -- Custom Market Insights has published a new research report titled “Multi Cancer Early Detection Market Size, Trends and Insights By Type (Liquid Biopsy,...
MD Anderson and ARTIDIS Announce Strategic Alliance to Advance Nanomechanical Technology Platform for Optimizing Cancer Treatment
03 oct. 2022 09h05 HE
|
ARTIDIS AG
HOUSTON and BASEL, Switzerland, Oct. 03, 2022 (GLOBE NEWSWIRE) -- ARTIDIS AG, the developer of the first nanomechanical technology platform for tissue analytics, and The University of Texas MD...
Pancreatic Cancer Treatment Market Size [2022-2029] | Industry Share, Revenue, Key Players, CAGR, Demand and Forecast
28 sept. 2022 07h22 HE
|
Fortune Business Insights
Pune, India, Sept. 28, 2022 (GLOBE NEWSWIRE) -- The global pancreatic cancer treatment market size is expected to rise substantially owing to increasing consumption of cigarettes and rising...
Global Pancreatic Cancer Treatment Market to Generate Revenue of $3.78 Billion by 2028 | AI is Slowly Budding to Improve Diagnosis Accuracy of Pancreatic Cancer
22 sept. 2022 09h36 HE
|
SkyQuest Technology Consulting Pvt. Ltd.
Westford,USA, Sept. 22, 2022 (GLOBE NEWSWIRE) -- Pancreatic cancer is 12th the deadliest forms of cancer, with a 5-year survival rate of just 15%. As a result, there is a strong growth momentum in...
Sermonix Pharmaceuticals Announces Top-Line Data From ELAINE 1 Phase 2 Study of Lasofoxifene Versus Fulvestrant Is Accepted for a Late-Breaking Oral Presentation at ESMO Congress 2022
25 août 2022 09h00 HE
|
Sermonix Pharmaceuticals Inc.
COLUMBUS, Ohio, Aug. 25, 2022 (GLOBE NEWSWIRE) -- Sermonix Pharmaceuticals Inc., a privately held biopharmaceutical company developing innovative therapeutics to specifically treat ESR1-mutated...